Alzheimer's Disease Trial, Recruiting NCT06451952 Sponsor: University of Bergen Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06451952
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be admitted to NKS Olaviken gerontopsychiatric hospital
  • You must have a diagnosis of dementia, at any stage and of any type
  • You must be 50 years old or older
  • Both men and women are eligible
  • You must have a notable level of agitation, as measured by a standard assessment tool called the CMAI (confirm with trial site for exact score details)

Who may not be able to join:

  • You may not be eligible if you are completely blind or have a significant problem with your vision in both eyes (confirm with trial site)
  • You may not be eligible if you are currently taking melatonin (a sleep supplement)
  • You may not be eligible if you are experiencing significant pain, as measured by a standard pain assessment tool called MOBID-2 (confirm with trial site for exact details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4798857354

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Bergen
Registry
ClinicalTrials.gov
Start date
30 September 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Cohen-Mansfield Agitation Inventory (CMAI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov